Mosunetuzumab Archives - Medical Conferences

Clinically meaningful outcomes for mosunetuzumab across follicular lymphoma subgroups

Presented By

Dr Sarit Assouline, Jewish General Hospital, Canada

Trial

Phase 1/2

Conference

EHA 2024

Type

Peer-reviewed article

12 August 2024 14:26

Presented By

Dr Elizabeth Budde, City of Hope National Medical Center, CA, USA

Trial

Phase 1/2

Conference

ASH 2023

Type

Peer-reviewed article

7 February 2024 14:59

Presented By

Prof. Stephen Schuster, University of Pennsylvania, USA

Conference

ASH 2019

Type

Peer-reviewed article

5 March 2020 09:50